Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,384 Cr
P/E Ratio
--
P/B Ratio
5.89
Industry P/E
36.55
Debt to Equity
1.19
ROE
-11.9 %
ROCE
-4.5 %
Div. Yield
0 %
Book Value
119.7
EPS
-68.71
CFO
₹362.90 Cr
EBITDA
₹714.38 Cr
Net Profit
₹291.01 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Astec Lifesciences
| -29.16 | 4.84 | -27.46 | -41.96 | -27.00 | 11.94 | 18.46 |
|
BSE Commodities
| 2.65 | 0.88 | 7.57 | 2.56 | 7.98 | 28.87 | -- |
|
BSE Small Cap
| -11.78 | 3.63 | 1.77 | 2.32 | 18.87 | 34.79 | 16.12 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Astec Lifesciences
| -7.31 | -37.45 | 22.25 | 11.22 | 195.24 | -13.94 | -3.65 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 610.00 | 754.12 | 25.75 | 33.47 | |
| 205.36 | 20,717.17 | 21.94 | 42.82 | |
| 57.07 | 546.73 | 390.52 | 0.66 | |
| 237.74 | 4,569.05 | 36.55 | 6.49 |
No Review & Analysis are available.
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl... urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited. Read more
Incorporated
1994
Chairman
Nadir B Godrej
Managing Director
--
Group
Godrej
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Astec Lifesciences Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Astec Lifesciences Ltd stood at ₹ 881 Cr as on 31-Mar-25
The share price of Astec Lifesciences Ltd is ₹707.90 (NSE) and ₹710.20 (BSE) as of 29-Apr-2025 09:44 IST. Astec Lifesciences Ltd has given a return of -27% in the last 3 years.
Astec Lifesciences Ltd has a market capitalisation of ₹ 1,384 Cr as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Astec Lifesciences Ltd is 5.89 times as on 28-Apr-2025, a 62% premium to its peers’ median range of 3.64 times.
Since, TTM earnings of Astec Lifesciences Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Astec Lifesciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Astec Lifesciences Ltd.
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
The prominent promoters of Astec Lifesciences Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Godrej Agrovet Limited |
64.75%
|
|
Nadir Burjorji Godrej |
2.06%
|
|
Ashok Vishwanath Hiremath |
1.99%
|
The chairman of the company is Nadir B Godrej, and the managing director is .
There is no promoter pledging in Astec Lifesciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,629
|
|
|
765
|
|
|
552
|
|
|
20,079
|
| Astec Lifesciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-51.21
|
|
Operating margin(%)
|
-28.83
|
|
Net Margin(%)
|
-34.82
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Astec Lifesciences Ltd was ₹-135 Cr.
₹3.50
(
